I had emailed the company about the schedule 4.22 and in a follow up email I asked if Clayton was still with Resverlogix, BDZ had sent me a PM indicating that he was no longer with Zenith so I wondered if he was no longer at Resverlogix as well....
Here's the cut and pastes:
Greetings Clayton or Sarah....
As you may or may not be aware I had the chance to talk briefly with Mr. McCaffrey in Toronto at the Bloom Burton conference. Please extend to him my sincere thanks for his taking the time to chat with me and also convey that I very much enjoyed the presentation.
I have a question concerning the recent SEDAR filing concerning the loan agreement arranged through Third Eye Capital. Specifically this part:
Schedule 4.22 hereto sets forth as of the Closing Date, a true and accurate summary of the clinical trial protocol and achievements to-date including (i) target sample size, (ii) current enrolment size, (iii) primary and secondary endpoints, (iv) list of participating sites; (v) average patient profile; (vi) description of drug, dosing, and route of administration; (vii) target duration of study and current status, (viii) target participation duration of patients; (ix) target events and events to-date; (x) target relative risk reduction and relative risk reduction to-date; (xi) events until interim analysis; (xii) assumed dropout rate and rate-to-date
The related schedule 4.22 is of course redacted so I am unable to see the information that was provided to the lenders. I was hoping you could explain to me how this does not constitute selective disclosure. Including in the loan agreement is an investment in options at what I hope will prove to be a very attractive price. As an investor I would appreciate being made aware of this information as well. Is that possible?
I look forward to hearing back at your earliest convenience.
Regards,
Sarah's reply:
Hello - this is to confirm I received your email and will look into a response for your question.
Best,
Sarah
My follow up:
Thanks Sarah,
Just one more quick question. Is Clayton still with Resverlogix?
And Sarah's reply:
Clayton is no longer employed with the company.
